Radiesse® Safety Study For the Treatment of Hands
Public ClinicalTrials.gov record NCT02904096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Radiesse® Post Approval Safety Study For the Treatment of Hands With Moderate to Very Severe Dorsal Volume Loss
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety of Radiesse implantation for very severe volume loss in the dorsum of the hand at 6 months after treatment.
Study identification
- NCT ID
- NCT02904096
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 256 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2016 (Actual)
- Primary completion
- Jan 9, 2019 (Actual)
- Completion
- Jan 9, 2019 (Actual)
- Last update posted
- Jan 13, 2020
2016 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigative Site #0010393 | Sacramento | California | — | — |
| Merz Investigative Site #0010321 | San Diego | California | — | — |
| Merz Investigative Site #0010358 | Vista | California | — | — |
| Merz Investigative Site #0010099 | West Hollywood | California | — | — |
| Merz Investigative Site #0010405 | New York | New York | — | — |
| Merz Investigative Site #0010406 | New York | New York | — | — |
| Merz Investigative Site #0010322 | Austin | Texas | — | — |
| Merz Investigative Site #0010125 | Plano | Texas | — | — |
| Merz Investigative Site #0010392 | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02904096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02904096 live on ClinicalTrials.gov.